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At the present ime it is uncertain whether or not the cytosolic and particulate forms of tissue transglutaminase are distinct and discrete enzymes. 
In this study a number of physical and immunological similarities between the two forms are demonstrated, indicating that they share some common 
epitopes, although their native confirmations may differ. 
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1, INTRODUCTION 
Transglutaminases are a group of acyl-transferases 
that catalyse the post-translations cross-linking of pro- 
teins via the formation of ~(~-glut~yl)lysine bridges 
[I]. These enzymes exist in both extracelldar forms 
(Factor XIII and prostate transglutaminase) and in- 
tracellular forms (epidermal, hair follicle and tissue 
transgiutaminase) [2-41. Tissue transglutaminase is 
thought to exist in two distinct forms, a predo~n~tly 
soluble cytosolic enzyme and an insoluble particulate 
enzyme [5,6]. Although no role has as yet been con- 
firmed for either form, it has been suggested that they 
may be involved in a number of calcium-mediated pro- 
cesses associated with the cell membrane and 
cytoskeleton [7-111, and with programmed cell death 
(apoptosis) [12]. Before the function of tissue trans- 
glutaminases can be fully understood, it is necessary to 
ascertain the relationship between the two forms since, 
at the present time, it is uncertain whether or not they 
are distinct and discrete enzymes. The aim of this study 
is to investigate any immunologic~ simil~ities that 
may exist between the two enzyme forms. 
2. EXPERIMENTAL 
Cytosolic and particulate transglutaminase were semi-purified 
from rat liver homogeni~d to 20% (w/v) in buffered non-ionic 
detergent (1% Lubrol-PX in 0.25 M sucrose, 5 mM Tris, pH 7.4, 
2 mM EDTA, 2 mM DTT, 1 mM PMSF) followed by anion ex- 
change (Mono-Q column) chromatography [131. Transglutaminase 
activity was measured by the 0” dependent incorporation of 
(‘%]putrescine into N,Ndimethylcasein [13], and antigen was 
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measured by a quantitative sandwich ELISA, utilising affinity 
purified goat anti-guinea pig liver cytosolic transglutaminase and rab- 
bit anti-rat liver cytosolic transglutaminase [13]. After dialysis 
against 5 mM Tris, pH 7.4, 2 mM EDTA, 2 mM DTT, further 
puri~cation of each enzyme form was carried out using a 3 ml affini- 
ty column of rabbit anti-cytosolic tr~~ut~in~e antibody linked 
to cyanogen bromide activated Sepharose. Antigen was eluted using 
10% (v/v) dioxane in 0.25 M glycine/HCl, pH 2.5, then immediately 
neutralised with 2.5 M Tris, and desalted to remove the dioxane on 
a Pharmacia PD-10 column using 5 mM Tris, pH 7.4, 2 mM EDTA 
as the eluting buffer. Purified fractions were then freeze-dried. Non- 
denatured samples of affinity purified particulate and cytosolic trans- 
glutaminase were electrophoresed on 7.5% (w/v) acrylamide gels in 
non-reducing conditions and then Western blotted onto nitrocellulose 
[14]. Samples, denatured by boiling in 40% (w/v) SDS, 10% (v/v) 
2-mercaptoethanol, were electrophoresed on 10% (w/v) acrylamide 
gels under reducing conditions [15] and then Western blotted onto 
nitrocellulose paper [14]. Western blots were immunoprobed with the 
affinity purified polyclonal anti-cytosolic transglutaminase antibody 
raised in goat, or mouse monoclon~ anti-guinea pig cytosolic trans- 
glutaminase antibody, and visualised using a Biorad biotin/strep- 
tavidin HRP amplification system, as per the manufacturers 
directions. Prior to immunoprobing with the monoclonal antibody, 
some Western blots of non-reduced particulate nzyme were treated 
at 37’C for 1 h with 0.5 units in Tris-buffered saline (TBS) (100 mM 
Tris-HCl, pH 7.4, 150 mM NaCl) plus 10 mM CaClt, of either 
lipase, collagenase, mannosidase, ghrcosidase or galactosidase. As a 
control, Factor XIII (Boehringer), electrophoresed and Western blot- 
ted under comparable conditions, was also subjected to these 
treatments. Western blots of cytosolic and particulate trans- 
glutaminase obtained from non-denaturing polyacrylamide gels were 
also probed with the HRP labelled lectins Concanavalin A, Triticum 
vu&ark and Bandeiraea stmp~icifo~ia, in TBS plus 10 mM CaClz, 
10 mM MgCIz and 10 mM MnCl2. 
3. RESULTS 
AS previously demonstrated [5,6], the cytosolic and 
particulate tr~sglutaminases are easily separable by 
anion exchange (Mono-Q) chromatography, with the 
particulate form eluting at 0.15-0.25 M NaCI and the 
cytosolic form eluting at 0.35-0.45 M NaCl (Fig. 1A). 
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Similarly, the two forms also differ in their elution pat- 
tern from a rabbit anti-cytosolic transglutaminase af- 
finity column, with the cytosolic form eluting first, 
after 2 column volumes of eluent (6 ml), and the par- 
ticulate form eluting after 4 column volumes (12 ml). 
Antigen profiles of anion exchange eluent fractions 
indicated that both affinity-purified goat anti-cytosolic 
transglutaminase and rabbit anti-cytosolic tran- 
sglutaminase cross-reacted with the particulate form 
(Fig. 1B). However, if the monoclonal anti-cytosolic 
transglutaminase antibody was used as either the cap- 
ture antibody or the visualising antibody in the sand- 
wich ELISA assay, only the cytosolic peak was 
observed (Fig. lC), indicating non-reactivity of the 
monoclonal antibody with the particulate form. 
Western blots of non-denaturing polyacrylamide 
gels, immunoprobed with polyclonal affinity purified 
goat anti-cytosolic transglutaminase confirmed the ex- 
pected differences in the relative electrophoretic 
mobilities of the two forms but further demonstrated 
the cross-reactivity of the antibody with both the par- 
ticulate and cytosolic forms. Similar blots im- 
munoprobed with monoclonal anti-cytosolic 
transglutaminase only demonstrated cross-reactivity 
with the cytosolic form (Fig. 2). However, when 
Western blots obtained from denaturing SDS- 
polyacrylamide gels were immunoprobed with the 
monoclonal antibody, both cytosolic and particulate 
forms were demonstrated (Fig. 3). Furthermore, the 
relative mobilities and calculated molecular masses 
(87 kDa in each case) were found to be comparable. 
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Fig. 1. Elution pattern of the particulate (p) and cytosolic (c) forms 
of transglutaminase on anion-exchange Mono-Q column (total 
elution volume 10 ml). (A) The enzyme activity profile. (B) Antigen 
profile using polyclonal antibody. (C) Antigen profile using 
monoclonal antibody. collagenase (Cg). 
Fig. 2. Western blots of semi-purified (Mono-Q column) cytosolic (c) 
and particulate (p) transglutaminase following non-denaturing 
polyacrylamide gel electrophoresis. (A) Blots immunoprobed with 
polyclonal antibody. (B) Blots immunoprobed with monoclonal 
antibody. (C) Blots of the particulate immunoprobed with 
monoclonal antibody following treatment with lipase (L) and 
Prior treatment of Western blots obtained from non- 
denaturing polyacrylamide gels with either lipase or 
collagenase also led to cross-reactivity of the particulate 
form with the monoclonal antibody (Fig. 2). The use of 
denaturing gel electrophoresis or the enzyme treatment 
of blots of the plasma transglutaminase Factor XIII did 
not produce a form capable of cross-reactivity with 
either the monoclonal or polyclonal antibodies (data 
not shown). Mannosidase, galactosidase or glucosidase 
treatment of Western blots did not produce a par- 
ticulate form capable of cross-reacting with the 
monoclonal. Western blots of the particulate or 
cytosolic transglutaminase previously separated by 
non-denaturing polyacrylamide gel electrophoresis and 
probed with the HRP-labeled lectins, Concanavalin A, 
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Fig. 3. Western blots of semi-purified (Mono-Q column) cytosolic (c) 
and particulate (p) transg~utaminase following denaturing SDS-gel 
efectrophoresis. (A) Blots immunoprobed with pdyclonal antibody. 
(B) Blots immunoprobed with monoclonal antibody. 
Triticum vulgaris and Bandeiraea sirnplicifolia, showed 
no reaction, confirming that mannose, glucose and 
galactose, respectively, were not components of either 
enzyme form. 
4. DISCUSSION 
Previous reports have indicated the molecular weight 
of the particulate transglutaminase, as calculated by 
size exclusion chromatography, to be 100 kDa, approx- 
imately 20 kDa greater than the known weight of the 
cytosolic form [5]. The data presented in this report in- 
dicate that when SDS-solubilised forms of the par- 
ticulate and cytosolic transglutaminases are subjected 
to SDS-PAGE, their molecular masses appear to be 
comparable, at 87 kDa. On an immunological basis our 
data also indicate that there is clearly a number of 
similarities between the two enzymes. The sugars man- 
nose, glucose and galactose do not appear to be present 
on either form, furthermore polyclonal antibodies rais- 
ed against the cytosolic enzyme also reacted with the 
particulate form, and with a greater avidity, as sug- 
gested by their relative elution patterns from an anti- 
cytosolic transglutaminase affinity column. Studies 
with the monoclonal anti-cytosolic transglutaminase 
antibody indicated that this antibody does not 
cross-react with particulate transglutaminase when in 
its native form suggesting that the epitope is either 
missing’ from the protein or masked in some way. 
However, since SDS-denatured forms of the particulate 
enzyme were found to react with this monoclonal an- 
tibody, both the cytosolic and particulate enzymes must 
possess the epitope for this antibody. Since denatura- 
tion of the particulate enzyme reveals the epitope, the 
suggestion is that in the native nzyme the epitope is 
masked, either by further post-translational modifica- 
tion as found in epidermal transglutaminase [ 161, by 
the binding of extraneous material during purification 
or by differences in the tertiary structure of the two en- 
zymes. Since SDS PAGE indicated that the two en- 
zymes have comparable molecular masses, a result 
contrasting with that obtained from exclusion 
chromatography (85 kDa for the cytosolic and 100 kDa 
for the particulate) each of the latter proposals are 
possible. Previous workers have indicated that tissue 
transglutaminase has a high affinity for the ex- 
tracellular matrix [17-191 and suggestions have been 
made that the binding of the cytosolic enzyme to col- 
lagen during cell fractionation may account for a 
number of its particulate properties. The binding of 
tissue transglutaminase to specific plasma membrane 
domains has also been noted [20]. The observation that 
treatment with either lipase or collagenase leads to 
cross-reactivity of non-denatured particulate trans- 
glutaminase with the monoclonal antibody suggests 
that the particulate enzyme does indeed associate with 
both lipids and collagen, and that this association may 
be responsible for masking the epitope. 
In conclusion, our data obtained from im- 
munological studies indicate that the two forms of 
tissue transglutaminase are far more closely related 
than previously documented, each carrying a number 
of similar epitopes. 
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